Journal of oncology (J Oncol)

Journal PubWeight™ 475.08‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. 2009 3.14
2 Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. 2009 1.84
3 Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. 2009 1.81
4 Ovarian cancer pathogenesis: a model in evolution. 2009 1.77
5 MicroRNAs as Novel Biomarkers for Breast Cancer. 2009 1.72
6 Cytomorphology of circulating colorectal tumor cells:a small case series. 2010 1.66
7 Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. 2010 1.63
8 Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood. 2011 1.60
9 Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. 2011 1.54
10 Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors. 2012 1.44
11 Akt: a double-edged sword in cell proliferation and genome stability. 2012 1.44
12 Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma. 2009 1.43
13 Claudin family of proteins and cancer: an overview. 2010 1.42
14 Adaptive radiation therapy for head and neck cancer-can an old goal evolve into a new standard? 2010 1.41
15 Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. 2010 1.40
16 Current strategies for identification of glioma stem cells: adequate or unsatisfactory? 2012 1.40
17 Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers. 2009 1.38
18 Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. 2012 1.36
19 Cancer stem cells in head and neck squamous cell carcinoma. 2010 1.31
20 Breast cancer in developing countries: opportunities for improved survival. 2010 1.31
21 Anticancer drugs from marine flora: an overview. 2011 1.30
22 Changing trends of breast cancer survival in sultanate of oman. 2010 1.29
23 Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. 2013 1.29
24 Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation. 2010 1.28
25 Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. 2012 1.27
26 Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. 2009 1.26
27 Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics. 2010 1.24
28 Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis. 2012 1.24
29 TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis. 2015 1.23
30 The Regulatory Role of MicroRNAs in EMT and Cancer. 2015 1.22
31 Breast cancer in low- and middle-income countries: an emerging and challenging epidemic. 2010 1.20
32 Improving Breast Cancer Control via the Use of Community Health Workers in South Africa: A Critical Review. 2010 1.19
33 Progress on antiangiogenic therapy for patients with malignant glioma. 2010 1.19
34 Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis. 2010 1.17
35 Molecular mechanisms of resistance to tumour anti-angiogenic strategies. 2010 1.17
36 A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. 2012 1.16
37 Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. 2011 1.15
38 Enchondroma versus Low-Grade Chondrosarcoma in Appendicular Skeleton: Clinical and Radiological Criteria. 2012 1.14
39 Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts. 2010 1.14
40 Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells. 2010 1.13
41 Decision-Making about the HPV Vaccine among Ethnically Diverse Parents: Implications for Health Communications. 2011 1.12
42 HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor. 2012 1.12
43 Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies. 2010 1.12
44 Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges. 2009 1.12
45 Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101. 2011 1.11
46 Matricellular proteins: a sticky affair with cancers. 2012 1.10
47 Targeting the tumor microenvironment: focus on angiogenesis. 2011 1.09
48 Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68. 2010 1.09
49 Intrahepatic sarcomatoid cholangiocarcinoma. 2010 1.08
50 Rare and challenging tumor entity: phyllodes tumor of the prostate. 2009 1.08
Next 50